Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-157815
Filing Date
2021-05-11
Accepted
2021-05-11 17:28:23
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d74270ds3.htm S-3 391624
2 EX-1.2 d74270dex12.htm EX-1.2 197175
3 EX-4.3 d74270dex43.htm EX-4.3 333197
4 EX-5.1 d74270dex51.htm EX-5.1 25694
5 EX-23.2 d74270dex232.htm EX-23.2 1841
6 GRAPHIC g74270g52p90.jpg GRAPHIC 3449
7 GRAPHIC g74270g86u57.jpg GRAPHIC 2582
8 GRAPHIC g74270g97j09.jpg GRAPHIC 58535
  Complete submission text file 0001193125-21-157815.txt   1033818
Mailing Address 480 ARSENAL STREET WATERTOWN MA 02472
Business Address 480 ARSENAL STREET WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256020 | Film No.: 21912607
SIC: 3841 Surgical & Medical Instruments & Apparatus